AQR Arbitrage’s Aimmune Therapeutics AIMT Stock Holding History

AQR Arbitrage’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-894,257	Closed	-$30.8M	–	1228
2020 Q3	$30.8M	Buy	+894,257	New	+$19M	1.12%	24

AQR Arbitrage's AIMT Position: Q4 2020 in Review

AQR Arbitrage sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 894,257 shares — an estimated $30.8M sold.

AQR Arbitrage first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $30.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

AQR Arbitrage reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
AQR Arbitrage sold 894,257 Aimmune Therapeutics shares in Q4 2020, an estimated $30.8M.
AQR Arbitrage first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
AQR Arbitrage's Aimmune Therapeutics position peaked at $30.8M in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on AQR Arbitrage's 13F filing for Q4 2020, filed 16 Feb 2021.